Advertisement
Screener

AIM IMMUNOTECH INC. (AIM) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

AIM IMMUNOTECH INC. Cash Flow Breakdown

Cash flow breakdown shows where AIM IMMUNOTECH INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $10.96M went out.
  • Fiscal year ended 2025-12-31: from investing, $1.85M came in.
  • Fiscal year ended 2025-12-31: from financing, $10.39M came in.
  • Fiscal year ended 2025-12-31: change in cash, $1.28M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew shares soldNot split outChange in cash
2025-12-31-$10.96M$1.85M$10.39M*$1.28M
2024-12-31-$14.89M$4.71M$6.44M*-$3.74M
2023-12-31-$21.27M-$832.00K-$21.61M
2022-12-31-$16.11M$10.99M-$5.04M
2021-12-31-$13.96M-$631.00K-$122.00K$13.04M-$4.73M*-$6.41M
2020-12-31-$10.37M-$9.16M-$355.00K$61.25M-$4.33M*$37.03M
2019-12-31-$9.07M-$6.15M-$340.00K$15.30M$1.42M*$1.17M
2018-12-31-$10.64M$92.00K-$264.00K$5.07M$4.63M*-$1.11M
2017-12-31-$7.94M$2.73M$2.42M$1.80M*-$996.00K
2016-12-31-$7.38M$2.92M$4.74M$293.00K
2015-12-31-$16.05M$6.35M$9.68M-$41.00K
2014-12-31-$13.96M$2.53M$12.82M$1.35M
2013-12-31-$16.83M$22.27M$249.00K-$7.10M*-$1.41M
2012-12-31-$13.14M-$16.07M$23.00M$5.31M*-$891.00K
2011-12-31-$10.10M$8.65M$0.00$1.62M*$183.00K
2010-12-31-$11.89M-$43.52M$292.00K-$55.15M
2009-12-31-$9.30M-$574.00K$55.57M$6.25M*$51.95M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew shares soldNot split outChange in cash
2026-06-30-$4.59M*-$112.00K*$537.00K*$8.25M*
2026-03-31-$2.72M-$37.00K$2.00M$3.59M*$2.83M
2025-12-31-$1.99M*-$95.00K*$2.72M*
2025-09-30-$5.08M*$296.00K*$6.65M*
2025-06-30-$1.53M*$754.00K*$105.00K*
2025-03-31-$2.36M$898.00K$660.00K-$803.00K
2024-12-31-$3.96M*$3.70M*$1.04M*
2024-09-30-$3.11M*$334.00K*
2024-06-30-$3.01M*$826.00K*$2.44M*
2024-03-31-$4.82M-$158.00K$2.83M*-$2.14M
2023-12-31-$9.76M*-$214.00K*
2023-09-30-$5.67M*-$336.00K*
2023-06-30-$2.16M*-$204.00K*
2023-03-31-$3.68M-$78.00K-$3.66M
2022-12-31-$6.07M*$3.36M*
2022-09-30-$4.97M*$250.00K*
2022-06-30-$2.31M*$7.72M*
2022-03-31-$2.76M-$346.00K-$3.10M
2021-12-31-$5.75M*$364.00K*$0.00*$125.00K*
2021-09-30-$3.46M*-$366.00K*$0.00*$30.00K*
2021-06-30-$1.72M*-$1.15M*-$29.00K*$0.00*-$4.73M*
2021-03-31-$3.04M$523.00K-$93.00K$12.89M$10.27M
2020-12-31-$2.85M*-$182.00K*-$90.00K*$3.18M*
2020-09-30-$2.99M*-$9.58M*-$89.00K*$17.25M*
2020-06-30-$1.27M*-$3.08M*-$90.00K*$15.05M*-$4.28M*
2020-03-31-$3.25M$3.68M-$86.00K$25.77M$26.12M
2019-12-31-$2.29M*-$5.29M*-$86.00K*-$4.00K*
2019-09-30-$2.54M*-$232.00K*-$85.00K*$9.62M*$1.90M*
2019-06-30-$2.78M*$472.00K*-$85.00K*$955.00K*
2019-03-31-$1.46M-$1.10M-$84.00K$4.73M$2.10M
2018-12-31-$2.42M*-$1.52M*-$83.00K*$166.00K*-$3.76M*
2018-09-30-$2.98M*$617.00K*-$84.00K*$140.00K*$2.79M*$487.00K*
2018-06-30-$2.70M*-$43.00K*-$78.00K*$2.44M*-$389.00K*
2018-03-31-$2.54M$1.04M-$19.00K$2.33M$1.74M*$2.54M
2017-12-31-$760.00K*$1.09M*$237.00K*$909.00K*
2017-09-30-$1.88M*$160.00K*$65.00K*$936.00K*-$719.00K*
2017-06-30-$2.31M*$997.00K*$1.24M*$517.00K*$446.00K*
2017-03-31-$2.99M$486.00K$875.00K-$1.63M
2016-12-31-$2.10M*-$27.00K*$50.00K*-$2.06M*
2016-09-30-$2.99M*$1.39M*$4.53M*$2.94M*
2016-06-30-$1.25M*$1.61M*$161.00K*$525.00K*
2016-03-31-$1.04M-$60.00K$2.00K-$1.10M
2015-12-31-$3.31M*$4.27M*$1.00K*$954.00K*
2015-09-30-$3.50M*$2.44M*$387.00K*-$681.00K*
2015-06-30-$4.98M*-$163.00K*$4.05M*-$1.10M*
2015-03-31-$4.26M-$192.00K$5.24M$786.00K
2014-12-31-$4.03M*$1.88M*$3.05M*$894.00K*
2014-09-30-$3.73M*$1.07M*$1.30M*-$1.35M*
2014-06-30-$3.31M*-$243.00K*$2.07M*-$1.49M*
2014-03-31-$2.90M-$177.00K$6.38M$3.30M
2013-12-31-$3.18M*$9.20M*$249.00K*-$7.06M*-$795.00K*
2013-09-30-$4.02M*$4.32M*$0.00*$292.00K*
2013-06-30-$3.78M*$3.51M*$0.00*-$282.00K*
2013-03-31-$5.85M$5.24M$0.00-$624.00K
2012-12-31-$4.96M*-$11.00M*$13.73M*$1.28M*-$946.00K*
2012-09-30-$2.70M*-$6.99M*$10.68M*$988.00K*
2012-06-30-$3.81M*$287.00K*$2.05M*-$1.48M*
2012-03-31-$1.67M$1.64M$569.00K*$547.00K
2011-12-31-$3.02M*$1.58M*$0.00*$518.00K*-$919.00K*
2011-09-30-$2.27M*$3.08M*$0.00*$1.14M*$1.94M*
2011-06-30-$2.98M*$2.83M*-$167.00K*
2011-03-31-$1.82M$1.16M-$673.00K
2010-12-31-$1.82M*$1.71M*-$1.00K*-$124.00K*
2010-09-30-$2.68M*$407.00K*$0.00*-$2.29M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CURIS INC (CRIS)United States$0.002B-0.05
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Silexion Therapeutics Corp (SLXN)$0.001B